Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2005
05/18/2005CN1202129C GDNF mutant and its medical application
05/18/2005CN1202128C Immunogenicity of modified protein
05/18/2005CN1202126C Recombinant Newcastle disease virus capable of being used as embryo vaccine
05/18/2005CN1201818C Vaccine
05/17/2005US6894158 Reacting nucleoside with cyanoethyl-N,N,N',N'-tetraisopropyl-phosphorodiamidite in presence of trifluoroacetic acid-diisopropylethylamine complex
05/17/2005US6894157 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
05/17/2005US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders
05/17/2005US6894153 Gene Any-RF; dormancy regulatory substance, process for producing the same and cell regulator for vital cells
05/17/2005US6894148 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/17/2005US6894147 Intermediate conductance calcium-activated potassium channels (IK1)
05/17/2005US6893878 Centrifugal spectrometer
05/17/2005US6893872 Pesticidal toxins
05/17/2005US6893870 Pancreas-derived plasminogen activator inhibitor
05/17/2005US6893869 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering
05/17/2005US6893868 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
05/17/2005US6893867 Molecular switch for regulating mammalian gene expression
05/17/2005US6893866 Flavivirus expression and delivery system
05/17/2005US6893865 Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles
05/17/2005US6893861 By reacting a trifluoroacetoacetic acid derivative with a microorganism of the species Escherichia coli or cell- free extracts derived therefrom
05/17/2005US6893859 Antiproliferative agent for treating diseases or conditions characterized by cellular hyperproliferation
05/17/2005US6893858 Human kcnq5 potassium channel, methods and compositions thereof
05/17/2005US6893854 Nuclease
05/17/2005US6893853 Nucleic acid fragments encoding chromatin associated proteins in plants and seeds; construction of a chimeric gene encoding all or a portion of the chromatin associated protein in sense or antisense orientation
05/17/2005US6893852 Phosphoenolpyruvate-sugar transport system (PTS); a gene encoding a protein constituting sucrose PTS provided by amplifying a region in coryneform bacterium by the cassette-ligation mediated PCR to obtain DNA encoding the PTS enzyme II
05/17/2005US6893845 Surface expression libraries of heteromeric receptors
05/17/2005US6893844 DNA encoding a new human hepatoma derived growth factor and producing method thereof
05/17/2005US6893843 Nucleic acids
05/17/2005US6893841 Nucleotide sequences coding polypeptide for use in tool in treatment of defects in protein transport
05/17/2005US6893840 Cytomegalovirus Intron A fragments
05/17/2005US6893839 Isolated cyclohexadepsipeptide synthetases and isolated nucleic acid sequences encoding the cyclohexadepsipeptide synthetases
05/17/2005US6893838 DADD, death activator death domain protein
05/17/2005US6893833 Use of NAD(P)H oxidase inhibitors to increase cellular uptake of glucose and in the treatment and/or prevention of diseases caused by insulin resistance or diseases related thereto, such as type II diabetes
05/17/2005US6893829 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
05/17/2005US6893827 Receptor function assay for G-protein coupled receptors and orphan receptors by reporter enzyme mutant complementation
05/17/2005US6893825 Gene expression marking
05/17/2005US6893824 Apparatus for detection and monitoring preferential gene expresssion patterns
05/17/2005US6893822 Electronic array for solid phase synthesis; kits
05/17/2005US6893820 Detection of methylated CpG rich sequences diagnostic for malignant cells
05/17/2005US6893817 Amino acid sequences and method for isolating bacteries from the type genus pseudomonas
05/17/2005US6893664 Particle delivery techniques
05/17/2005US6893643 Comprises exogenous nucleotide sequences which encode exogenous amino acid sequences; infection of host cell with recombinant Yellow Fever Virus provides for expression of exogenous nucleic acid and production of antigen
05/17/2005US6893638 Methods for treating b cell lymphoma using CD80-specific antibodies
05/17/2005US6893636 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
05/17/2005US6893634 Without inflammatory or other immune response side effects; injection or implantation in tissue containing cancer growth; porous cellulose sulphate and polydimethyldiallylammonium membrane; breast and/or pancreatic tumors
05/17/2005US6893562 Wicking structure, which channels droplets of liquid away from a membrane in communication with a plurality of wells
05/17/2005US6893546 Method for separating a chemical or biological compound in a mixture of similar compounds by diffusion in a medium such as a gel
05/17/2005CA2375673C Dna sequences derived from the genome of the papillomavirus hpv39, their application to in vitro diagnostic and to the production of immunogen compositions
05/17/2005CA2304987C Inhibition of an fgf-binding protein using ribozymes
05/17/2005CA2248144C Horse endothelin-b receptor gene and gene products
05/17/2005CA2235845C Prostaglandin d synthase-specific monoclonal antibody
05/17/2005CA2202390C Keratinocyte growth factor analogs
05/17/2005CA2182393C Dna mutagenesis by random fragmentation and reassembly
05/17/2005CA2158017C Production of glycolate oxidase in methylotrophic yeast
05/17/2005CA2132374C Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
05/17/2005CA2115151C Tau/neurofilament protein kinases pk40 and pk36
05/17/2005CA2075147C Quantification of nucleic acid
05/12/2005WO2005043593A2 System for processing a workpiece
05/12/2005WO2005042784A2 Device and method for high-throughput quantification of mrna from whole blood
05/12/2005WO2005042782A1 Methods for reducing seizure-induced neuronal damage
05/12/2005WO2005042779A1 Method of screening remedy or preventive for diabetes or diabetic nephropathy
05/12/2005WO2005042777A2 App/ena antisense
05/12/2005WO2005042774A2 Method for linking sequences of interest
05/12/2005WO2005042754A1 Retroviral vectors for delivery of interfering rna
05/12/2005WO2005042753A1 Production of human glycosylated proteins in transgenic insects
05/12/2005WO2005042752A2 Symbiotic mutant of pea (pisum sativum l.)
05/12/2005WO2005042751A1 Controlling the spread of infective agents
05/12/2005WO2005042750A1 Method for stable gene-amplification in a bacterial host cell
05/12/2005WO2005042749A1 Expression system for the b subunit of cholera toxin
05/12/2005WO2005042748A1 Coloured fusion proteins
05/12/2005WO2005042747A2 Plant isoflavonoid hydroxylases and methods of use thereof
05/12/2005WO2005042746A1 Bacterial virulence factors and uses thereof
05/12/2005WO2005042745A1 Meg1 endosperm-specific promoters and genes
05/12/2005WO2005042744A1 A recombinant protein with cancer suppression action, its encoding gene and use
05/12/2005WO2005042743A2 Humanization of antibodies
05/12/2005WO2005042742A1 Monkey npy y4 recepotr and method of evaluating compound
05/12/2005WO2005042741A2 METHODS AND COMPOSITIONS FOR TREATING 5alpha-REDUCTASE TYPE 1 AND TYPE 2 DEPENDENT CONDITIONS
05/12/2005WO2005042739A1 Novel plasmids and utilization thereof
05/12/2005WO2005042737A1 Method of constructing transgenic dendritic cell
05/12/2005WO2005042736A1 Cell culture supplement for the in vitro cultivation of cells and a method for culturing cells
05/12/2005WO2005042728A2 Immortalized avian cell lines for virus production
05/12/2005WO2005042719A2 Methods for treating and preventing ischemia-reperfusion injury using rna interfering agents
05/12/2005WO2005042714A2 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
05/12/2005WO2005042708A2 METHOD OF DESIGNING siRNAS FOR GENE SILENCING
05/12/2005WO2005042705A2 Short interfering rna and micro-rna compounds and methods of designing, making and using the same
05/12/2005WO2005042702A2 Compositions of stabilized dna for coating microprojections
05/12/2005WO2005042695A2 Lipoparticles comprising proteins, methods of making, and using the same
05/12/2005WO2005042693A2 Hla-e chimeric molecule
05/12/2005WO2005042582A1 Process for producing antibody
05/12/2005WO2005042579A1 Anti-sars virus antibody, hybridoma producing the antibody and immunoassay reagent using the antibody
05/12/2005WO2005042576A1 Clq RELATED PROTEIN
05/12/2005WO2005042574A1 High troughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein
05/12/2005WO2005042572A1 Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
05/12/2005WO2005042570A1 Hcv ns3-ns4a protease resistance mutants
05/12/2005WO2005042560A2 Non-viral delivery of compounds to mitochondria
05/12/2005WO2005042558A1 Iap nucleobase oligomers and oligomeric complexes and uses thereof
05/12/2005WO2005042552A2 Modulation of sglt2 expression
05/12/2005WO2005042030A1 Treatment of proliferative diseases using an antisense iap oligomer and chemotherapeutic agent
05/12/2005WO2005042018A2 C-class oligonucleotide analogs with enhanced immunostimulatory potency
05/12/2005WO2005042006A2 Use of ephrins and related molecules to regulate cellular proliferation
05/12/2005WO2005041972A1 Phosphodiesterase 9 inhibition as treatment for obesity-related conditions
1 ... 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 ... 4023